You can catch monkeypox if you have close physical contact with someone who is showing symptoms. This includes touching and being face-to-face.
Viral disease
Scientists identify characteristics to better define long COVID
A research team supported by the National Institutes of Health has identified characteristics of people with long COVID and those likely to have it. Scientists, using machine learning techniques, analyzed an unprecedented collection of electronic health records (EHRs) available for… Read More ›
NIH scientists identify mechanism that may influence infectivity of SARS-CoV-2 variants
Scientists at the National Institutes of Health have found that a process in cells may limit infectivity of SARS-CoV-2, and that mutations in the alpha and delta variants overcome this effect, potentially boosting the virus’s ability to spread. The findings… Read More ›
NIAID issues new awards to fund “pan-coronavirus” vaccines
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $36.3 million to three academic institutions to conduct research to develop vaccines to protect against multiple types of coronaviruses and viral… Read More ›
Impact of COVID-19: over 153 million confirmed cases and 3.2 million related deaths have been reported to WHO
Of the 23.1 million cases reported in the South-East Asia Region to date, over 86% are attributed to India. Despite the extensive spread of the virus, COVID-19 cases to date appear to be concentrated predominantly in high-income countries (HICs). The 20 most impacted HICs account for almost half (45%) of the world’s cumulative COVID-19 cases, yet they represent only one eighth (12.4%) of the global population.
Experimental Antiviral for COVID-19 Effective in Hamster Study
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
Single-Dose COVID-19 Nasal Vaccine Limits Infection in Monkeys
A single dose of an experimental COVID-19 vaccine delivered into the nose of rhesus macaques protected their lungs and nasal region from SARS-CoV-2 infection, a new study from National Institutes of Health scientists and colleagues shows.
Specimen-news.com 